XML 34 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2016
Income Tax Disclosure [Abstract]  
Summary of Net Deferred Tax Asset

Our net deferred tax asset consisted of the following at December 31, 2016 and 2015:

 

 

 

December 31,

 

 

 

2016

 

 

2015

 

Deferred tax asset:

 

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

42,436,541

 

 

$

42,315,384

 

Deferred compensation

 

 

1,681,158

 

 

 

1,474,625

 

Depreciation and amortization

 

 

842,073

 

 

 

1,010,636

 

Research and development credits

 

 

3,788,955

 

 

 

3,788,752

 

Accrued expenses

 

 

391,365

 

 

 

314,633

 

Impairment loss

 

 

730,831

 

 

 

850,334

 

Other

 

 

438,039

 

 

 

248,933

 

Total deferred tax assets

 

 

50,308,962

 

 

 

50,003,297

 

Less: Valuation allowance

 

 

(50,308,962

)

 

 

(50,003,297

)

Net deferred tax asset

 

$

 

 

$

 

 

Summary of Income Tax Provision (Benefit) from Income Taxes

The income tax provision (benefit) from income taxes consists of the following at December 31, 2016 and 2015:

 

 

 

Years Ended December 31,

 

 

 

2016

 

 

2015

 

Federal

 

 

 

 

 

 

 

 

Current

 

$

 

 

$

 

Deferred

 

 

(1,069,610

)

 

 

(1,246,071

)

State

 

 

 

 

 

 

 

 

Current

 

 

 

 

 

 

 

 

Deferred

 

 

763,945

 

 

 

(213,826

)

Total

 

 

(305,665

)

 

 

(1,459,897

)

Change in valuation allowance

 

 

305,665

 

 

 

1,459,897

 

Income tax provision (benefit)

 

$

 

 

$

 

 

Summary of Provision for Income Taxes Using Statutory Federal Tax Rate

The provision for income taxes using the statutory federal tax rate as compared to our effective tax rate is summarized as follows:

 

 

 

December 31,

 

 

 

2016

 

 

2015

 

Federal income tax rate

 

 

(34.0

)%

 

 

(34.0

)%

State income tax rate, net of federal benefit

 

 

(5.8

)%

 

 

(4.8

)%

Deferred tax true-up

 

 

(1.7

)%

 

5.0

%

Other permanent differences

 

 

-

%

 

0.1

%

Net operating loss expiration

 

 

31.4

%

 

-

%

 

 

 

(10.1

)%

 

 

(33.7

)%

Change in valuation allowance

 

 

10.1

%

 

 

33.7

%

 

 

 

%

 

 

%